Results 151 to 160 of about 12,305,089 (195)
Some of the next articles are maybe not open access.
B‐Cell Activating Properties of Polymyxin B
Scandinavian Journal of Immunology, 1978Polymyxins are known to be inhibitors of certain polyclonal B cell activators such as lipopolysac‐charide and dextransulphate. However, increased specific responses to hapten‐coupled mitogens have been reported after the addition of polymyxins to superoptimal conjugate doses.
C I, Smith, L, Hammarström
openaire +2 more sources
Biochemistry, 2000
The Gram-negative bacterial endotoxin lipopolysaccharide (LPS) is a major inducer of sepsis. The natural cyclic peptide polymyxin B (PMB) is a potent antimicrobial agent, albeit highly toxic, by virtue of its capacity to neutralize the devastating effects of LPS. However, the exact mode of association between PMB and LPS is not clear. In this study, we
H, Tsubery +3 more
openaire +2 more sources
The Gram-negative bacterial endotoxin lipopolysaccharide (LPS) is a major inducer of sepsis. The natural cyclic peptide polymyxin B (PMB) is a potent antimicrobial agent, albeit highly toxic, by virtue of its capacity to neutralize the devastating effects of LPS. However, the exact mode of association between PMB and LPS is not clear. In this study, we
H, Tsubery +3 more
openaire +2 more sources
Contact dermatitis to polymyxin B
Contact Dermatitis, 2008M M, Jiaravuthisan, J G, DeKoven
openaire +2 more sources
THE PHARMACOLOGY OF POLYMYXIN A, B, AND D
Annals of the New York Academy of Sciences, 1949G, BROWNLEE, S R M, BUSHBY, E I, SHORT
openaire +2 more sources
The identification of polymyxin B sulphate
Journal of Chromatography A, 1970A, Haemers, P, De Moerloose
openaire +2 more sources